Is PHR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PHR. It does not provide personalized investment advice.

PHR (Phreesia, Inc.) Stock Analysis - Financials

Phreesia, Inc. (PHR) is a publicly traded Healthcare sector company. As of October 19, 2026, PHR trades at $10.96 with a market cap of $679.06M and a P/E ratio of 58.53. PHR moved -0.18% today. Year to date, PHR is -35.34%; over the trailing twelve months it is -51.91%. Its 52-week range spans $7.77 to $32.76. Analyst consensus is buy with an average price target of $13.33. Rallies surfaces PHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PHR's key financials?

PHR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PHR recently traded at $10.96. Market cap is $679.06M. P/E ratio is 58.53. Revenue is $507.79M.

PHR Key Metrics

Key financial metrics for PHR
Metric	Value
Price	$10.96
Market Cap	$679.06M
P/E Ratio	58.53
EPS	$0.18
Dividend Yield	0.00%
52-Week High	$32.76
52-Week Low	$7.77
Volume	56.30K
Avg Volume	0
Revenue (TTM)	$507.79M
Net Income	$10.45M
Gross Margin	0.00%

PHR Analyst Consensus

11 analysts cover PHR: 0 strong buy, 6 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.33.

Common questions about PHR

What are PHR's key financials?: PHR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PHR recently traded at $10.96. Market cap is $679.06M. P/E ratio is 58.53. Revenue is $507.79M.
Is PHR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PHR. It does not provide personalized investment advice.